SC 13G: INTELLIGENT BIO SOLUTIONS INC.
Ticker: INBS · Form: SC 13G · Filed: Nov 14, 2024 · CIK: 1725430
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by INTELLIGENT BIO SOLUTIONS INC..
Risk Assessment
Risk Level: low
Filing Stats: 1,813 words · 7 min read · ~6 pages · Grade level 9.5 · Accepted 2024-11-14 16:31:30
Key Financial Figures
- $0.01 — me of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti
Filing Documents
- alyeska-inbs093024.htm (SC 13G) — 103KB
- 0001172661-24-005254.txt ( ) — 105KB
(a)Name of Issuer
Item 1. (a)Name of Issuer Intelligent Bio Solutions Inc.
(b)Address of Issuer’s Principal
Item 1. (b)Address of Issuer’s Principal Executive Offices 135 West, 41ST Street, 5th Floor New York, NY 10036
(a)Names of Person Filing
Item 2. (a)Names of Person Filing: (i) Alyeska Investment Group, L.P. (ii) Alyeska Fund GP, LLC (iii) Anand Parekh
(b) Address of Principal Business Office
Item 2. (b) Address of Principal Business Office: (i) 77 West Wacker Drive, 7th Floor Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor Chicago, IL 60601
(c)Citizenship
Item 2. (c)Citizenship: (i) Alyeska Investment Group, L.P. - Delaware (ii) Alyeska Fund GP, LLC - Delaware (iii) Anand Parekh - United States of America
(d)Title of Class of Securities
Item 2. (d)Title of Class of Securities Common Stock, par value $0.01 per share
(e) CUSIP No
Item 2. (e) CUSIP No.: 36151G600 CUSIP No. 36151G600 SCHEDULE 13G Page 6 of 9 Pages
If
Item 3.If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) x An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) x A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) A group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: CUSIP No. 36151G600 SCHEDULE 13G Page 7 of 9 Pages Item 4.Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: Please refer to items 5-9 of the cover pages attached hereto (b) Percent of class: Please refer to item 11 of the cover pages attached hereto (c) Number of shares as to which the person has: Please refer to items 5-8 of the cover pages attached hereto The reporting persons are the beneficial owners of 206,199 shares of Common Stock, par value $0.01 per share of the Issuer and hold warrants to purchase 1,102,030 shares of the Issuer’s Common Stock, par value $